Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research. Issue 5 (4th May 2018)

Record Type:: Journal Article
Title:: Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research. Issue 5 (4th May 2018)
Main Title:: Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research
Authors:: Marcellin, Fabienne
Fontaine, Hélène
Serfaty, Lawrence
Sogni, Philippe
Carrieri, Maria Patrizia
Abstract:
Is Part Of:: Expert review of anti-infective therapy. Volume 16:Issue 5(2018)
Journal:: Expert review of anti-infective therapy
Issue:: Volume 16:Issue 5(2018)
Issue Display:: Volume 16, Issue 5 (2018)
Year:: 2018
Volume:: 16
Issue:: 5
Issue Sort Value:: 2018-0016-0005-0000
Page Start:: 377
Page End:: 380
Publication Date:: 2018-05-04
Subjects:: Cannabis -- CHC -- co-infection -- HCV -- hepatitis -- HIV -- liver disease -- marijuana -- steatosis
Anti-infective agents -- Research -- Periodicals
616.90461
Journal URLs:: http://informahealthcare.com ↗
http://www.future-drugs.com/publication.asp?publicationid=7 ↗
http://www.tandfonline.com/toc/ierz20/current ↗
DOI:: 10.1080/14787210.2018.1473764 ↗
Languages:: English
ISSNs:: 1478-7210
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3842.002981
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 6651.xml